Your Specialist on GLP • Nationwide delivery

Your Specialist on GLP Peptides
across Indonesia

GLP+ supplies Semaglutide, Tirzepatide and Retatrutide across Indonesia, in both vial and pen form. Powered by Peptide+, Indonesia's most-reviewed peptide source.

Receptor activation tiers
Semaglutide
Single
GLP-1
Tirzepatide
Dual
GLP-1GIP
Retatrutide
Triple
GLP-1GIPGlucagon
99%+
Lab-verified purity
3
GLP-1 compounds
Vial & Pen
Both formats stocked
5.0 ★
65 Google reviews

Three GLP compounds, one specialist source

Semaglutide, Tirzepatide and Retatrutide each activate a different number of incretin receptors. Pick the depth of research you need, in vial or pen form.

Single receptor

Semaglutide

GLP-1 agonist

The original GLP-1 weight management peptide. Best understood, longest research history, and a strong baseline for first-time peptide research.

Vial 10mgIDR 6,600,000
Pen 10mgIDR 7,600,000
Dual receptor

Tirzepatide

GLP-1 + GIP agonist

A dual-action peptide that activates GLP-1 and GIP receptors. Stronger metabolic response than Semaglutide in published research, with the most popular vial/pen split.

Vial 10mgIDR 3,400,000
Pen 10mgIDR 4,400,000
Triple receptor

Retatrutide

GLP-1 + GIP + Glucagon agonist

The newest generation weight management peptide. Activates three incretin receptors, currently the most-requested compound in our Bali catalog. Available in 5mg, 10mg and 30mg.

Vial 10mgIDR 3,500,000
Pen 10mgIDR 4,500,000

Specialist comparison: Semaglutide vs Tirzepatide vs Retatrutide

The side-by-side view researchers actually use to choose. Generalist peptide stores skip this because they cannot compare apples to apples.

Specification Semaglutide Tirzepatide Retatrutide
Receptor target GLP-1 GLP-1 + GIP GLP-1 + GIP + Glucagon
Mechanism tier Single agonist Dual agonist Triple agonist
Typical research dose frequency Once weekly Once weekly Once weekly
Key clinical trial STEP-1 (NEJM 2021) SURMOUNT-1 (NEJM 2022) TRIUMPH-1 Phase 3 (May 2026)
Sizes available 10mg 10mg 5mg, 10mg, 30mg
Vial 10mg price IDR 6,600,000 IDR 3,400,000 IDR 3,500,000
Pen 10mg price IDR 7,600,000 IDR 4,400,000 IDR 4,500,000
Best for Baseline research, longest track record Dual mechanism, established results Latest research, deepest metabolic engagement

The GLP weight management timeline

From single-receptor baseline to triple-agonist research, in under a decade.

2017
Semaglutide approved
Once-weekly Semaglutide injectable approved for type-2 diabetes research. Weight management indication followed in 2021.
2022
Tirzepatide approved
Dual GLP-1 + GIP agonist. SURMOUNT-1 publishes the following year, establishing the dual-receptor research category.
2023
Retatrutide Phase 2 in NEJM
Triple GLP-1 + GIP + Glucagon agonist. Mean -24.2% body weight reduction at 48 weeks, the largest published change for any incretin peptide.
May 2026
Retatrutide TRIUMPH-1 Phase 3
Topline results announced May 21, 2026. Up to -28.3% mean body weight reduction at 80 weeks across 2,339 adults; -30.3% in the 104-week extension subgroup. All doses met primary endpoint. Available now via GLP+.

Vial or pen: which format suits your research?

Every compound is stocked in both formats. The pen is faster to use; the vial is more cost-effective and flexible. Both contain the same lab-verified peptide.

Vial (reconstitute and draw)

  • Lowest cost per mg
  • Flexible dosing in any increment
  • Requires bacteriostatic water and insulin syringe (we can include both)
  • Available 5mg, 10mg, 30mg depending on compound

Pen (pre-filled, ready to use)

  • No reconstitution, no mixing
  • Dial-a-dose, click-to-inject mechanism
  • Faster and more discreet for travel
  • Best for first-time peptide research

Trusted by Indonesia's GLP research community

5.0 ★★★★★

From 65 verified Google reviews at our parent operation (Peptide+ Bali, Canggu flagship).  Read all reviews on Google

★★★★★

"Currently I've been using 3 peptides: Retatrutide, NAD+ and GHK-Cu to improve my health. Reta for 2 weeks already, love it. My appetite is more controlled and I feel full faster."

G
Gied K.
Verified Google review
★★★★★

"They dropped it off to me within the hour. Some of the products are better priced. Reta is damn good and the NAD+ was epic. Thank you to Lisa."

L
Luicious S.
Verified Google review
★★★★★

"My favourite peptide company in Bali. Best pricing and fast delivery. I highly recommend buying your peptides here."

R
Ryan C.
Local Guide • 52 reviews
★★★★★

"Best peptides in Bali. I got a good consultation and the delivery was quick. All around good customer service."

D
Dennis K.
Verified Google review

Why buy GLP peptides in Indonesia from GLP+

GLP+ is built differently from generalist peptide stores. We carry three compounds. Not 40. While generalist catalogs chase breadth across the entire peptide universe, GLP+ goes deep on the GLP family. That focus is why researchers in Indonesia choose us when the compound matters more than the catalog.

Three compounds, not 40

Generalist peptide stores juggle dozens of compounds at once. GLP+ stocks only Semaglutide, Tirzepatide and Retatrutide. Deep stock, deep product knowledge, no scattergun catalog.

Research-grade reference

Every compound page cites the actual published clinical trial behind it (STEP-1, SURMOUNT-1, Retatrutide Phase 2 in NEJM). We treat researchers as researchers, not buyers.

Direct from Peptide+ supply

No resellers. GLP+ ships directly from the same lab-verified inventory powering Indonesia's most-reviewed peptide brand (5.0 stars, 65 verified Google reviews).

Frequently asked questions

Everything you need to know before ordering GLP peptides in Indonesia.

What is the difference between Semaglutide, Tirzepatide and Retatrutide?

All three are incretin peptides studied for weight management. Semaglutide activates one receptor (GLP-1). Tirzepatide activates two (GLP-1 and GIP). Retatrutide activates three (GLP-1, GIP and Glucagon). More receptors generally means a stronger metabolic effect in published research, but the most appropriate compound for your study depends on your research goals.

Should I order the vial or the pen?

Vials are cheaper per mg and offer more dosing flexibility but require reconstitution with bacteriostatic water. Pens are pre-filled, click-to-dose, no mixing required, and easier to travel with. If this is your first peptide research, most clients choose the pen.

Do you deliver everywhere in Indonesia?

Yes. GLP+ ships GLP weight management peptides nationwide. Major cities (Jakarta, Bali, Surabaya, Bandung, Medan, Yogyakarta, Lombok) receive priority handling. Same-day dispatch is standard for orders confirmed before 5 PM; remote areas typically arrive within 2-3 days.

How is my order packaged for the Indonesian climate?

All GLP peptides ship in temperature-controlled packaging with cold-chain protection, critical for the Indonesian climate. Pens and vials arrive intact and ready to refrigerate.

What payment methods do you accept?

We accept Indonesian bank transfer, QRIS, and major digital wallets. All pricing is quoted in IDR with no hidden fees or currency conversion. Our WhatsApp team will guide you through payment once you confirm your order.

Is this for research only?

All peptides sold by GLP+ are intended for research purposes only. We do not provide medical advice, dosing guidance, or treatment recommendations. Please consult a qualified medical professional for any clinical decisions.

Ready to order GLP peptides in Indonesia?

Get same-day responses from our team. The full catalog is one message away.

Message Us on WhatsApp
Order on WhatsApp